-
Study findings have been published in the Science Direct, Vaccine journal 126998 to assess a double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority and lot-to-lot consistency of single component oral cholera vaccine
-
A quadrivalent vaccine, by covering strains of both influenza A and influenza B, provides a broader protection and significantly reduces the risk of vaccine mismatch
-
The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is approved for active immunization against smallpox, Mpox, and related orthopoxvirus infections in adults aged 18 and older. It is administered as a 2-dose injection, with doses spaced 4 weeks apart.
-
Bharat Biotech said that its Covid-19 vaccine Covaxin has an excellent safety record without any vaccine-associated incidents of blood clots, thrombocytopenia, etc.
-
This single-dose vaccine is intended for individuals aged 18 and older at a heightened risk of Chikungunya virus exposure, transmitted primarily through infected mosquitoes.
-
WHO also issued recommendations on the advice of SAGE for new vaccines for dengue and meningitis, along with immunisation schedules and product recommendations for COVID-19
-
The US has started the phase 1 clinical trial of a new investigational universal flu vaccine candidate
-
Scientists say research has reached a turning point. A vaccine shot could shrink tumors and stop cancer from coming back.
-
Authorities need to revitalise immunisation campaign and urge people to shed vaccine hesitancy in view of rising Covid cases
-
The letter also called for the government to pay the medical expenses of those left sick or disabled by vaccines
-
Cervavac is a vaccine that aims to prevent or reduce the number of cervical cancer cases, the fourth most common kind of cancer found in women.
-
The total tally of Covid cases was recorded at 4.46 crore
-
"COVID is not over yet. I have directed all concerned to be alert and strengthen surveillance. We are prepared to manage any situation."
-
The surge in the number of Covid-related hospitalisations in the United States in the last few weeks comes as a warning signal to other countries as well.
-
For the first time since the beginning of the pandemic in early 2020, a majority of Americans dying from Covid were at least partially vaccinated, according to the new analysis of federal and state data.
-
Hyderabad: Telangana today holds its pride of place as the only state to manufacture the goat pox vaccine in India. The vaccine, which is 100 percent effective against the lumpy skin disease, is being produced by the Veterinary Biological Research Institute (VBRI) in Telangana, with the support of the Animal Husbandry Department. VBRI found that […]
-
Biological E Limited (BE) announced that the CDSCO approved the Phase 3 infants clinical trial data and recommended for manufacture of its 14-valent paediatric vaccine against Streptococcus pneumoniae infection in single-dose and multidose presentations.
-
New Delhi: The cumulative number of Covid-19 vaccine doses administered in the country crossed the 208.95 crore mark on Thursday, with over 12 crore precaution doses administered till 7 am on August 18. “208.95 cr Total Vaccine doses (93.86 cr Second Dose and 12.92 cr Precaution Dose) have been administered so far under Nationwide Vaccination […]
-
New Delhi: The Indian Council of Medical Research (ICMR) has received 31 bids from manufacturers showing interest in developing vaccine against the monkeypox virus after the medical body floated the Expression of Interest (EOI) for the development of vaccine and diagnostic kits, a source said on Saturday. According to the source, of the total 31 […]
-
Los Angeles: The BA.5 Omicron subvariant, now the dominant coronavirus strain in the US, is four times more resistant to Covid-19 vaccines, according to a new study published in Nature. The study found the variant is four times more resistant to messenger RNA vaccines than earlier strains of Omicron, which include Pfizer and Moderna Covid-19 […]